Patient trials are set to commence in the second quarter of 2025, with plans to expand the platform to other cancers and non-cancer indications.
Founders
Khatija Ali
Company Description
BioSapien is a drug delivery platform specializing in localized cancer treatment, focusing on minimizing systemic side effects through its flagship product, MediChip, a 3D-printed slow-release delivery platform.